首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5774篇
  免费   482篇
  国内免费   12篇
耳鼻咽喉   52篇
儿科学   144篇
妇产科学   88篇
基础医学   776篇
口腔科学   109篇
临床医学   505篇
内科学   1189篇
皮肤病学   74篇
神经病学   714篇
特种医学   266篇
外科学   657篇
综合类   96篇
预防医学   546篇
眼科学   163篇
药学   355篇
中国医学   10篇
肿瘤学   524篇
  2022年   39篇
  2021年   78篇
  2020年   71篇
  2019年   91篇
  2018年   117篇
  2017年   80篇
  2016年   106篇
  2015年   107篇
  2014年   136篇
  2013年   203篇
  2012年   257篇
  2011年   240篇
  2010年   149篇
  2009年   142篇
  2008年   255篇
  2007年   243篇
  2006年   252篇
  2005年   249篇
  2004年   245篇
  2003年   234篇
  2002年   217篇
  2001年   207篇
  2000年   183篇
  1999年   153篇
  1998年   97篇
  1997年   65篇
  1996年   59篇
  1995年   62篇
  1994年   74篇
  1993年   70篇
  1992年   121篇
  1991年   100篇
  1990年   92篇
  1989年   110篇
  1988年   86篇
  1987年   94篇
  1986年   104篇
  1985年   84篇
  1984年   64篇
  1983年   74篇
  1982年   59篇
  1981年   48篇
  1979年   74篇
  1978年   51篇
  1977年   43篇
  1976年   54篇
  1975年   41篇
  1974年   50篇
  1973年   42篇
  1972年   41篇
排序方式: 共有6268条查询结果,搜索用时 328 毫秒
1.
2.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
3.
The identification of EGFR mutations in non‐small‐cell lung cancer is important for selecting patients, who may benefit from treatment with EGFR tyrosine kinase inhibitors. The analysis is usually performed on cytological aspirates and/or histological needle biopsies, representing a small fraction of the tumour volume. The aim of the present investigation was to evaluate the diagnostic performance of this molecular test. We retrospectively included 201 patients with primary adenocarcinoma of the lung. EGFR mutation status (exon 19 deletions and exon 21 L858R point mutation) was evaluated on both pre‐operative biopsies (131 histological and 70 cytological) and on the surgical specimens, using PCR. Samples with low tumour cell fraction were assigned to laser micro‐dissection (LMD). We found nine (4.5%) patients with EGFR mutation in the lung tumour resections, but failed to identify mutation in one of the corresponding pre‐operative, cytological specimens. Several (18.4%) analyses of the pre‐operative biopsies were inconclusive, especially in case of biopsies undergoing LMD and regarding exon 21 analysis. Discrepancy of mutation status in one patient may reflect intra‐tumoural heterogeneity or technical issues. Moreover, several inconclusive results in the diagnostic biopsies reveal that attention must be paid on the suitability of pre‐operative biopsies for EGFR mutation analysis.  相似文献   
4.
5.
6.
7.
8.
李强  张昱苹  谢东 《海南医学》2002,13(3):18-20
目的:探讨高分辨率CT(HRCT)对颞部疾病的检查价值。方法:对43例颞部疾病患者行常规CT和高分辨率CT(HRCT)检查所获图像对比分析,并讨论HRCT的检查技术和图像后处理。结果:HRCT对病变的显示率及病变引起骨质破坏的程度,病变边缘,轮廓的显示均明显优于常规CT,尤其能清楚显示常规CT难以显示的中耳及内耳的细微结构,结论:高分辨率CT是颞部疾病的首选检查方法,使用高分辨率CT对颞部疾病的检查给临床提供更多,更准确的诊断信息。  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号